Idexx Laboratories (IDXX) Invested Capital (2009 - 2026)

Idexx Laboratories (IDXX) has reported Invested Capital for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Invested Capital rose 28.86% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (up 28.86% YoY), while the FY2025 annual figure was $2.1 billion, down 7.13% from the prior year.
• Invested Capital came in at $2.1 billion for Q1 2026 at Idexx Laboratories, up from $2.1 billion in the prior quarter.
• The five-year high for Invested Capital was $2.2 billion in Q4 2024, with the low at $639.8 million in Q1 2022.
• Average Invested Capital over 5 years is $1.6 billion, with a median of $1.7 billion recorded in 2024.
• Across the five-year window, Invested Capital slipped 22.77% in 2022 and soared 70.54% in 2023, its largest moves.
• Year by year, Invested Capital stood at $1.4 billion in 2022, then surged by 58.34% to $2.2 billion in 2023, then increased by 1.39% to $2.2 billion in 2024, then retreated by 7.13% to $2.1 billion in 2025, then rose by 1.49% to $2.1 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $2.1 billion, $2.1 billion, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.